Balance Sheet for Vertex Pharmaceuticals Incorporated (VRTX)

$ 223.25   0.18 (+0.08%) Volume: 1.02m 4:00 PM EST Dec 6, 2019
After Hours:  $ 223.25 0.00 (0.00%) Volume: 33.69k 5:52 PM EST Dec 6, 2019
Statement: View:
Assets [+] in Millions of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 2,650 1,665 1,184 715 625
Restrictable Cash 26 1 48 79 8
Marketable Securities 518 423 251 328 762
Accounts Receivable 410 281 200 174 76
Loans Receivable - - - - -
Other Receivables 67 105 35 - -
Receivables 476 386 235 189 90
Inventories, Raw Materials 10 21 6 9 9
Inventories, Work in Progress 88 74 57 41 21
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 27 17 15 8 2
Inventories, Other 124 112 78 57 31
Inventories, Adjustments & Allowances - - - - -
Inventories 124 112 78 57 31
Prepaid Expenses 74 62 36 22 18
Current Deferred Income Taxes - - - - 4
Other Current Assets - - 17 13 7
Total Current Assets 3,843 2,649 1,832 1,407 1,547
Land and Improvements - - - - -
Buildings and Improvement 761 752 657 638 632
Machinery, Furniture and Equipment 503 470 429 395 363
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 1,263 1,222 1,086 1,034 994
Gross Fixed Assets 1,263 1,222 1,086 1,034 994
Accumulated Depreciation (451) (432) (388) (336) (278)
Net Fixed Assets 812 789 698 698 716
Intangibles 87 29 284 284 29
Cost in Excess 50 50 50 50 40
Non-Current Deferred Income Taxes 1,500 1 - - -
Other Non-Current Assets 41 27 12 29 3
Total Non-Current Assets 2,403 897 1,065 1,091 788
Total Assets 6,246 3,546 2,897 2,499 2,335
Liabilities [+] in Millions of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 212 147 107 135 83
Short Term Debt 10 23 319 87 32
Notes Payable - - - - -
Accrued Expenses 858 603 268 223 221
Accrued Liabilities 858 603 268 223 221
Deferred Revenues - 238 79 16 17
Current Deferred Income Taxes (1,512) (121) 17 3 0
Other Current Liabilities 41 (203) 18 45 15
Total Current Liabilities 1,120 807 793 506 368
Long Term Debt 582 584 521 739 793
Deferred Income Tax - 6 134 110 15
Other Non-Current Liabilities 109 106 (186) 49 62
Minority Interest - 14 182 154 21
Capital Lease Obligations 582 584 521 516 512
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 690 710 948 1,052 891
Total Liabilities 1,811 1,517 1,740 1,559 1,260
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 4,435 2,029 1,157 940 1,075
Common Par 3 3 2 2 2
Additional Paid in Capital 7,421 7,157 6,507 6,198 5,777
Cumulative Translation Adjustments - - - - -
Retained Earnings (2,989) (5,120) (5,374) (5,262) (4,705)
Treasury Stock - - - - -
Other Equity Adjustments 1 (12) 21 2 1
Total Capitalization 4,435 2,029 1,454 1,164 1,356
Total Equity 4,435 2,029 1,157 940 1,075
Total Liabilities & Shareholder's Equity 6,246 3,546 2,897 2,499 2,335
Cash Flow 2,087 92 (84) (588) (743)
Working Capital 2,723 1,842 1,039 901 1,178
Free Cash Flow 1,175 586 180 (411) (564)
Invested Capital 4,435 2,029 1,157 1,164 1,356
Shares Outstanding - Common Class Only 255 253 248 246 242
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 255 253 248 246 242
Total Common Shares Outstanding 255 253 248 246 242
Treasury Shares 0 - - - -
Basic Weighted Shares Outstanding 254 249 245 241 235
Diluted Weighted Shares Outstanding 259 253 245 241 235